Trials / Unknown
UnknownNCT05705960
Chestnut Consumption on Modulation of Gut Microbiota and Metabolic Parameters
The Effect of Chestnut Consumption on Modulation of Gut Microbiota and Metabolic Parameters
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (estimated)
- Sponsor
- Universidade Nova de Lisboa · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The chestnut tree (Castanea sativa Mill.) is a species widely cultivated in Portugal, which is a major producer of chestnuts. Nuts are nutritionally interesting, not only because of their content of vitamins, minerals, and phytochemicals but also of their high fiber content. Fiber, as it is not digested by humans, has a preponderant role in the intestinal microbiota, for its maintenance, and, consequently, has an impact on metabolic status. The inclusion of foods rich in these components, and with extensive local production, can be an excellent strategy for improving the metabolic parameters of the population. The main objective of this single group assignment clinical trial is to evaluate the effect of including roasted chestnuts in the daily diet on the composition and diversity of the intestinal microbiota. It is also intended to evaluate metabolic parameters to determine the impact of this intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Chestnut | Daily consumption of roasted chestnut (150g) for 14 days |
Timeline
- Start date
- 2022-11-15
- Primary completion
- 2023-03-01
- Completion
- 2023-03-01
- First posted
- 2023-01-31
- Last updated
- 2023-01-31
Locations
1 site across 1 country: Portugal
Source: ClinicalTrials.gov record NCT05705960. Inclusion in this directory is not an endorsement.